# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-18-006001
Filing Date
2018-05-14
Accepted
2018-05-11 19:23:46
Documents
7
Effectiveness Date
2018-05-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | defa14a0518_aytubioscience.htm | DEFA14A | 14698
2 | GRAPHIC | slide_1.jpg | GRAPHIC | 99269
3 | GRAPHIC | slide_2.jpg | GRAPHIC | 167622
4 | GRAPHIC | slide_3.jpg | GRAPHIC | 62876
5 | GRAPHIC | slide_4.jpg | GRAPHIC | 18424
6 | GRAPHIC | slide_5.jpg | GRAPHIC | 176348
7 | GRAPHIC | slide_6.jpg | GRAPHIC | 137566
| Complete submission text file | 0001213900-18-006001.txt |  | 928365

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 18828397
SIC: 2834 Pharmaceutical Preparations